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LOCKDOWN EXIT AND CONTROL OF THE
COVID-19 EPIDEMIC: GROUP TESTS CAN
BE MORE EFFECTIVE
Abstract
The lack of efficient mass testing tools for SARS-CoV-2 virus that causes Covid-19 has
contributed to the accelerated spread of the epidemic. Infected people are unaware that
they are spreading the disease during the incubation period as well as in asymptomatic
cases or cases with mild symptoms. To limit the number of victims of the epidemic, the
strategy adopted by most affected countries is therefore social distancing or complete
lockdown, a strategy that can only be beneficial for a limited time, given its economic and
social cost. Today, the most feasible way out of the stalemate requires widespread screen-
ing of the population. Such screening would make it possible to isolate infected people
and allow others to leave the lockdown. However, production capacity for SARS-CoV-2
tests is limited. Although production is increasing, it will not allow for sufficiently system-
atic and frequent screening to permit the lifting of health restrictions. We here describe
how the usefulness of each test can be amplified by applying it to the mixture of samples
from several individuals. This technique, called group testing, has already been success-
fully applied on SARS-CoV-2. We show how the group-test method must be calibrated to
maximize the usefulness of each available test.
• To stop the spread of the epidemic, lockdown is now the core strategy of the most affected
countries, but it is too costly to be sustainable. Mass screening could break the deadlock.
• The lack of tests currently limits this screening to a few tens of thousands of people per week
in France, and the production of tests is not increasing fast enough to envisage an exit from the
current lockdown.
• The group-testing technique multiplies the usefulness of each test. A group test, carried out on
the mixture of samples taken from n people, when it proves negative, makes it possible to end
the lockdown for all members of the group.
• Themethod requires precise calibration of group sizes to optimize its efficiency. It is most useful
when prevalence is low, i.e. the infected proportion of the population at the time of testing is
low.
• Under a prevalence scenario of 2%, each test can allow, on average, 18 people to exit lockdown
and return to work.
• The usefulness of the tests justifies massive investment in increasing production, particularly as
group tests significantly increase their effectiveness.
• Our approach demonstrates the value of the proven method of group testing, which needs to
be experimented with on a larger scale.
IPP Policy Brief # 54
Lockdown Exit and Control of the Covid-19 Epidemic: Group Tests Can be More Effective
Introduction
Which strategy to exit lockdown?
In the absence of mass capacities for testing SARS-CoV-
2 infections, lockdown (or compulsory social distancing
measures in WHO terminology) is the only option avail-
able to contain the current Covid-19 epidemic. Symptoms
appear in some infected people, and after an incubation
period of up to two weeks. During this period, and longer
for asymptomatic carriers, the infected person carries the
virus without knowing it, and therefore has a high chance
of infecting others.
Restrictions on mobility come at a high economic, social
and human cost. The financial cost is being mostly ab-
sorbed by the public budget deficit, but the economic cost
is likely to explode if the situation proves to be long last-
ing, or if new waves of infections come later. This policy
brief focuses on the economic cost, forwhich it is easier to
give quantitative estimates, which should be interpreted
as a conservative estimate of the total cost.
The main obstacle on the path out of lockdown is the risk
that some individuals carrying the virus will infect others.
While waiting for an effective treatment or vaccine, ex-
iting lockdown without sufficiently controlled conditions
would lead to a second wave of the epidemic, hitting hos-
pitals and healthcare workers already weakened by the
first. In previous epidemics, the second and third waves
were even more deadly than the initial outbreak.1
There is hope that serological tests will soon be standard-
ized to identify people who have developed immunity.
These people developed at least partial immunity against
the SARS-CoV-2, and may be protected from getting in-
fected a second time. Even in the best case scenario in
which they could all be identified and their immunity was
total, releasing only these people from lockdown would
be insufficient to restart economic activities as they are
too few of them. An estimate by Imperial College (Flax-
man, Mishra, Gandy, et al., 2020) tells us that no more
than 7% of the French population has been infected.2
To avoid a new wave of the epidemic, more than 50%
needs to be immunized. Given today’s estimated mor-
1The last four pandemics, namely the Spanish flu in 1918, the Asian
flu in 1957, the Hong Kong H3N2 flu in 1968, and the A (H1N1) flu of
2009, were all marked by several waves, the first ones being less deadly
than those that followed (Miller et al., 2009).
2The mean estimated value is 3%, but the error margins are high.
Prevalence is probably between 1% and 7%.
tality rate of approximately 3%, reaching such a propor-
tion would imply almost 7 Million fatalities in the Euro-
pean Union. Identifying those who have developed im-
munity will therefore not be enough for a safe exit from
lockdown.
Testing is a scarce resource
The best strategy possible to safely relax lockdown is to
identify a large number of healthy people through mass
screening of the population. This can be done with the
help of existing "PCR" tests, the results of which are now
available in less than 24 hours. This test has already made
it possible to isolate people with a positive result so that
they do not infect healthy people. Above all, it can clear
people who test negative to be released from lockdown,
allowing the gradual recovery of the country’s economic
and social life.
Inmost countries, testing capacity is not increasing rapidly
enough to satisfy the needs for systematic screening at
the individual level. OnMarch 28, the French government
declared that only 84,000 tests are being conducted per
week, with a target of around 350,000 tests per week.
TheUnited States plans to reach 1.2million tests perweek
for a population of 330 million. Even in Germany, where
there are 500,000 tests per week, the order of magni-
tude is still a long way from that of generalized individ-
ual testing, which would allow many people under lock-
down to return to work. Each test is a scarce and valuable
resource, and its usefulness must be maximized. This is
precisely what is made possible by the technique of group
testing, which has already been experimentedwith Covid-
19; for example, in Israel, the United States, Germany and
South-Korea.3
Using group tests
The principle of group testing dates back to the work of
Dorfman (1943) and syphilis tests for US military recruits.
A sample must first be taken from each individual, but in-
stead of performing the test on a single swab, samples
from members of the group are mixed. A single test is
performed on this mixture, to reveal the presence or ab-
sence of the virus in the mixture. This method represents
a loss of accuracy if the test is positive because we do
not know who carries the virus. But if the test is nega-
3At the Technion - Israel Institute of Technology, in hospitals in Ne-
braska, and at the University Hospital of Goethe University Frankfurt
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tive, we know that all members of the group are healthy
individuals. A single test, if negative, therefore provides
information on the status (infected or not) of several indi-
viduals, which multiplies the usefulness of each test, and
allows us to optimize the use of this rare resource.
A key issue is the choice of group size. If the groups are
too large, the result will too often be positive, providing
little information. If the groups are too small, group test-
ing will not deliver its full potential. In this policy brief,
we discuss three different strategies for implementing the
group-test method, depending on the chosen objective:
1. measuring the proportion of the population that is in-
fected, known as prevalence
2. organizing the exit from lockdown
3. individually identifying the infected people
We will see that in all three cases, group testing gives re-
sults that save a significant number of tests.
It is important to note that testing each person once is
not a sufficient solution. A person who is not infected at
the time of the test can become infected afterwards. This
implies that a strategy for mass exit from lockdown must
be based both on periodic group tests and on monitoring
the social interactions of infected people, in order to very
quickly detect and isolate outbreaks as soon as they recur.
Practical application of group tests
Screening consists of a sample collection step and a test-
ing step. Sampling is performed by trained medical staff
using a disposable swab to extract material from the up-
per respiratory tract. The sample must then undergo sev-
eral treatments: inactivation of the SARS-CoV-2 virus; ex-
traction of genetic material; multiplication of the genetic
material and detection of virus genetic markers through
PCR (Polymerase Chain Reaction).
The sampling stage involves relatively light medical equip-
ment and can be performed by medical personnel trained
in a few hours to perform the required procedures. Al-
though there may be occasional strain on the supply
of swabs, their technological simplicity means that their
availability can be greatly increased. On the other hand,
detecting the virus in samples by PCR requires access to
reagents and specialized machines, as well as the avail-
ability of highly qualified technicians. There is wordlwide
shortage of necessary reagents and scaling up production
is difficult.
The group test consists of mixing the samples obtained
from n individuals, and applying all the following steps
only on the mixture of these samples. If the test result
is negative, no one in the group is infected. If the test re-
sult is positive, then at least one of the group members is
infected.
PCR procedures are more than 95% reliable in virus de-
tection. However, in some cases, individuals can be ill
from Covid-19 while their organisms have already cleared
out SARS-CoV-2 from their upper respiratory tract. Non-
detection of these cases is not due to a technical limita-
tion of PCR testing, but hinges on the distinction between
Covid-19 medical cases and SARS-CoV-2 carriers. Group
testing does not exacerbate such cases, as they would re-
turn negative whether tested individually or in a group.
Since group testing involves dilution of samples, it may
push PCR to its detection limits when applied to large
groups. Research conducted at the Technion Israël Insti-
tute of Technology showed that PCR is able to identify a
positive sample combined in a group of 64. These results
will need to be reproduced and validated if the method is
to be generalized at a large scale.
What objectives can the group-testing
method achieve?
The value of group tests in estimating viral preva-
lence
The first objective - to establish the proportion of peo-
ple carrying the virus - is essential in the fight against the
epidemic. Knowing better the prevalence rate allows to
control the spread of infections, to estimate the propor-
tion of serious cases, or to estimate the lethality of the
virus. It is also essential for identifying which geographi-
cal areas and which age or socio-economic categories are
most affected.
At the moment, several countries rely on proxies such as
hospital admissions or death numbers to monitor the pro-
gression of the epidemics. However, not all serious cases
reach the hospital, and this proportion probably fluctuates
as hospitals become overcrowded and guidelines change.
Deaths due to Covid-19 are also counted approximately
only. In addition, the length of the period of incuba-
tion and worsening of symptomsmeans that this informa-
tion comes late in relation to the extent of the spread of
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the epidemic. For example, estimates obtained as of 30
March 2020 by the Imperial College epidemiology team
(Flaxman, Mishra, Gandy, et al., 2020) are imprecise, rang-
ing from 1 to 7%.
The simplest method would be to test a randomly se-
lected sample froma national population (or from the pop-
ulation of a region or department, to obtain geographic
estimates). The amount of individual tests needed to ob-
tain a sufficiently precise estimate would be very high
whereas the group-test method would allow equivalent
or better precision with far fewer tests.
Assuming a prevalence of 2% (i.e. 2% of the population
is infected), a set of 12,000 tests on randomly selected
individuals yields a margin of error of 0.25% (see Box 1),
which is small enough for the results to be used to guide
public policy decisions.
A similar error margin can be obtained with the group-
test method, by creating instead 600 groups of 20 people
(same number of people), and thus using only 600 tests
instead of 12,000. This represents a drastic saving in the
number of tests to be performed. The group size, set here
at 20 people, could be further increased to optimize per-
formance with a fixed number of tests.4 In practice, the
exact prevalence is unknown, and accuracy may be some-
what lower than this estimate.5 The savings in the number
of tests, however, are still considerable.
Austria recently conducted a national testing campaign, in
which 5 people out of 1544 returned positive. This gives
an estimate of the virus prevalence of 0.33%, with a confi-
dence interval ranging from 0.12% to 0.76%. Testing 500
groups of 48 people would have returned a similar esti-
mate with a confidence interval would range from 0,26%
to 0,41%. In this practical application, group testingwould
allow to cut the number of PCR tests by a factor 3 while
being much more accurate.
Optimizing group size to allow exit from lockdown
We are seeking to maximize the number of people al-
lowed to return to work. The objective is that each test
should allow release of a maximum number of healthy
people. Each individual test releases a maximum of one
person. Conversely, a group test, if it is negative, allows
the release of all members of the group. Wewill see that it
4For a fixed number of tests, performance is optimal when about 80%
of the groups contain at least one infected person. However, this does
increase the number of samples required.
5If prevalence is actually 3%, using 600 groups of 20 people, the con-
fidence interval obtained is somewhatwider, between 2.66%and 3.37%.
is possible to choose a group size such that each PCR test
authorizes, on average, the release of a number of people
well above one.
We can therefore design the following procedure. Let p
be the prevalence of the virus (the proportion of the pop-
ulation carrying the virus), and n the size of each tested
group. For the moment, we assume that individuals are
randomly assigned to groups, and that each individual in
a group that tests positive remains under lockdown.
If n is too large, it becomes very likely that a group will
contain a carrier of the virus. A large proportion of groups
will test positive, and most tests will not be very informa-
tive. If n is too small, each negative result will only allow a
small number of individuals to be released from lockdown.
The challenge is therefore to choose n optimally.
The probability of an individual carrying the virus is p (for
example, 2%). The probability of being healthy is, sym-
metrically, 1 − p (in this example, 98%). A group gets a
negative result if no individual is infected. The probability
of this event is (1 − p)n (or 54.5% in this example, with
a group of 30 people). In case of a negative result, a test
will release n people. On average, each test on a randomly
constructed group frees N = n × (1 − p)n people (in our
example, about 16 people).
The objective is to choose n, for a given prevalence p, in
order to maximize the effect of each test. A mathematical
calculation (first-order condition) yields thatnmust satisfy
the following condition:
n =
−1
log(1− p)
≈
1
p
For low prevalences, the optimal group size corresponds
to the inverse of the prevalence. The higher the preva-
lence of the virus, the smaller groups should be. Thus, it
is possible to recalculate, on average, how many individu-
als each test allows to be released (column (3) in Table 1).
For a prevalence of 2%, it is in fact optimal to form groups
of about 50 individuals. In comparison, an individual test
releases on average 1− p individuals (the probability that
the test is negative). The ratio of the average number of
individuals released with a group test to the average num-
ber released with an individual test is shown in column (4)
of Table 1.
How much should we, collectively, be willing to pay for
each test performed? Aside from the social and human
cost of lockdown and of the epidemic itself, we can give an
approximation of the economic cost (which therefore rep-
4
IPP Policy Brief # 54
Lockdown Exit and Control of the Covid-19 Epidemic: Group Tests Can be More Effective
The aim is to estimate the infected proportion of the population (prevalence) and the accuracy of the result, with both individual
and group tests. Accuracy depends on the actual level of prevalence. A prevalence of p is assumed, e.g. 2% of the population is
infected. A randomly selected individual therefore has a probability of 1− p (in this case, 98%) of not being a carrier of the virus.
Individual tests. If the individuals are chosen randomly, then the proportion of infected people that will be measured in the sample,
which is assumed to follow a binomial law, has a 95% chance of falling within the range of 1.76% to 2.27%. This range is due to
the fact that the sample is an imperfect representation of the population.
Group tests. The probability that nomember of a group of 20 people is infected, yielding a negative test for that group, is (1−p)20 =
(1 − 2%)20 = 66.8%. The probability that a group will test positive is therefore 33.24% (i.e. 100 - 66.8). Assume we have 600
groups, and the proportion with a positive group test is assumed to follow a binomial law. The proportion of groups testing
positive therefore has a 95% probability of being in the range between 29.5% and 37.0%. By doing the previous steps in the
opposite direction, we can calculate the level of prevalence to which these thresholds correspond: respectively 1.73% and 2.28%
(because 100− (1− 1.73%)20 = 29.5% and 100− (1− 2.28%)20 = 37.0%).
Both methods therefore provide very close intervals, using far fewer tests for the second.
Panel 1: Calculation of confidence intervalsl : l l ti f i t r l
resents a lower bound for the social cost). If putting a per-
son under lockdown costs society q euros, then each test
saves about qN euros (the individual cost multiplied by
the average number of people released from lockdown).
Although the economic cost remains difficult to mea-
sure, as a first approximation we can estimate the cost
of putting an individual under lockdown in terms of GDP
per capita. Suppose that, in the absence of a test, uni-
versal lockdown is required for two months. The cost to
society of putting an individual under lockdown is then at
least equal to two months of GDP per capita6. For the
European Union, with a GDP per capita of about 31,000
euros per year, this represents a cost q = 5,167 euros.
Let us try to measure the savings achieved by each indi-
vidual test and each group test, using the same example
of a 2% virus prevalence. In individual testing, the result
has a 98% chance of being negative. Each individual test
therefore frees an average of 0.98 people, avoiding a cost
of 5,063 euros.
Now consider the case of group testing. With such a
prevalence, the optimal value of n is 50 people. The prob-
ability that the test result is negative is then only 36%
(0.9850), but since each group is relatively large, a test re-
leases an average of 18.2 people (0.36 × 50 =18.2). A
single group test avoids, on average, a cost of 94,083 eu-
ros.
The last column of Table 1 reveals the economic cost
avoided by each group test, clearly indicating that the pro-
6INSEE provides an estimate of the effects of lockdown for the first
month at 33% of GDP in its last point de conjoncture du 26mars (INSEE,
2020), taking into account working from home and the fact that some
people are allowed to return to their workplace. Our figures are there-
fore more pessimistic for the economic cost, but can be easily adjusted.
duction of tests is of considerable value to society and
justifies substantial investment. The usefulness of the
group-test method decreases as the level of prevalence
increases.
Table 1: Optimal strategy for group testing,
depending on virus prevalence
(1) (2) (3) (4) (5)
Preva- Optimal Average Relative Avoided
lence size number power cost
(p) (n) of “released” of group in euros
(N ) test (qN )
1% 99 36,60 36,97 189 129
2% 49 18,21 18,58 94 083
5% 19 7,17 7,55 37 046
10% 9 3,49 3,87 18 016
20% 4 1,64 2,05 8 466
30% 3 1,03 1,47 5 317
40% 2 0,72 1,20 3 720
Note: We assume that putting an individual under lockdown costs society the
equivalent of the EU’s GDP per capita in relation to the duration of lockdown.
Interpretation : For a prevalence level of 1%, the optimal size of the test groups
is 99 individuals. On average, each test releases 36.6 individuals, i.e. 36.97 times
more individuals than an individual test. This represents an average avoided eco-
nomic cost of 189,129 euros.
Source : Authors’ calculations.
Note that it is not necessary for groups to be selected ran-
domly. Testing all members of a production unit (e.g., a
factory or assembly line) at the same time would signif-
icantly improve the power of the group-testing method.
This is because if any member of a group is positive
and has frequent and necessary contacts, it is likely that
the other members are also infected. This is also true
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for households.7 Creating groups in this way can also
facilitate the organization of sampling.
Using group tests to obtain individual results
Even when it comes to obtaining individual results, the
group-testing method can limit the number of tests re-
quired. Testing each individual requires as many tests as
there are individuals. However, if a group of size n is cho-
sen, in the event of a negative result, it is possible to give a
result for all its members simultaneously. Dorfman’s orig-
inal protocol, already implemented by the Technion Insti-
tute of Technology, Frankfurt University Hospital, andNe-
braska hospitals, consists of two steps. The first is a group
test. If the test is negative, it can be directly deduced that
none of the group members is infected. If the initial group
tests positive, the individuals are all tested separately. As-
suming that the two steps are done consecutively, each
individual is therefore testedwith amaximumof two sam-
ples (only one if the group is tested negative).
We can then calculate the average total number of tests
used per individual. If the group tests negative (which
happens with probability (1−p)n as explained above), we
use 1/n test per individual. If the initial group tests posi-
tive (which happens with probability 1− (1− p)n), we use
1/n test per individual in the first round, and one test per
individual in the second round. The average total number
of tests used per individual, denoted as T (n), can there-
fore be expressed as:
T (n) =
1 + (1− (1− p)n)n
n
Here, with the objective of obtaining individual results,
the optimal group size should minimize T (n). For a preva-
lence of 2%, the average number of tests performed per
individual is minimized with groups of 8 individuals (n =
8). Each test provides on average the status (infected or
not) of 3.7 individuals, a clear productivity gain compared
to using only individual tests.
Other methods have been proposed, for instance by
Sinnott-Armstrong, Klein, and Hickey (2020). In general,
it is possible to further increase the power of group test-
ing beyond the above factor by using more sophisticated
protocols involving a higher number of samples. Our ob-
7For example, suppose a prevalence of 2%, and assume that an in-
fected member of a couple has an 80% chance of infecting the other
member. It is then optimal to make groups of 42 couples or 84 people.
Each test then makes it possible, on average, to release 31 people - a
much higher performance than with randomly constructed groups.
jective here is to show the usefulness of group testing,
even when it comes to obtaining individual results.
Conclusion
Mass screening is essential for solving today’s health cri-
sis. Its deployment is currently restricted by our produc-
tion capacities, but these can be boosted tenfold by the
group-testingmethod. Themethod needs to be optimized
and tested on a large scale to reveal its full potential. It
is nevertheless promising and justifies substantial invest-
ment. Themethodwill then have to be adjusted according
to the objective (identifying healthy carriers of the virus,
obtaining individual results...) and the target population
(prevalence being higher, for example, in certain regions
and population groups).
On its own, group testing will not be enough to allow an
end to lockdown. It must be supplemented with an ade-
quate combination of personal protective equipment, so-
cial distancing and contact tracing. Testing will probably
need to be organized on a regular basis, and would proba-
bly benefit from being combined with monitoring of inter-
actions, in order to trace contamination chains as quickly
as possible.
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